RBC Capital reiterated an Outperform rating and $34.00 price target on Sagent Pharmaceuticals (NASDAQ: SGNT) after meeting with management. The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE